Literature DB >> 5634987

Responses of fetal rat bone to thyrocalcitonin in tissue culture.

J Friedman, W Y Au, L G Raisz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5634987     DOI: 10.1210/endo-82-1-149

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  13 in total

1.  Calcium involvement in free radical effects.

Authors:  R Bracci
Journal:  Calcif Tissue Int       Date:  1992-12       Impact factor: 4.333

2.  Effects of forskolin on bone resorption in the absence and presence of parathyroid hormone and calcitonin.

Authors:  H H Conaway; R L Abraham; C L Wadkins
Journal:  Calcif Tissue Int       Date:  1987-05       Impact factor: 4.333

3.  Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo.

Authors:  I R Garrett; B F Boyce; R O Oreffo; L Bonewald; J Poser; G R Mundy
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 4.  Drugs for disorders of bone: pharmacological and clinical considerations.

Authors:  G R Mundy; L G Raisz
Journal:  Drugs       Date:  1974       Impact factor: 9.546

5.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.

Authors:  J Pfeilschifter; G R Mundy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  Vitamin A, bone and joint.

Authors:  B Mazieres
Journal:  Clin Rheumatol       Date:  1982-12       Impact factor: 2.980

7.  Regulation of cellular calcium metabolism and calcium transport by calcitonin.

Authors:  A B Borle
Journal:  J Membr Biol       Date:  1975-04-23       Impact factor: 1.843

8.  Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.

Authors:  D J Hosking; S R Heller
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 9.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.

Authors:  S Takahashi; S Goldring; M Katz; S Hilsenbeck; R Williams; G D Roodman
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.